Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Samsca approved in Japan for autosomal dominant polycystic kidney disease

March 26, 2014

Ipsen reports findings from phase IIa study of Dysport for neurogenic detrusor overactivity

March 19, 2014

Novel spirocyclic diamine derivatives with activity in animal models of CKD

March 17, 2014

World Kidney Day: Early diagnosis and more accessible solutions for chronic kidney disease

March 13, 2014

Topline results released from phase II study of GCS-100 for chronic kidney disease

March 11, 2014

Fibrotech completes phase Ia study of FT-011 for diabetic nephropathy

March 10, 2014

Cumberland Pharmaceuticals acquires drug for hyponatremia

March 4, 2014

La Jolla Pharmaceutical signs agreement with George Washington University for LJPC-501

Feb. 28, 2014

Ardelyx licenses NaPi-2b phosphate inhibitor program to Sanofi

Feb. 25, 2014

Dosing completed in phase II trial of GCS-100 for chronic kidney disease

Feb. 24, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...